102 results about "Pseudoephedrine" patented technology

The present invention provides for devices and methods for vending regulated products, particularly controlled substances, including those containing pseudoephedrine. The present invention allows for the identification of consumers through reliable log-in-procedures, allows the consumer to select items, validates whether the purchase request complies with regulations, to facilitate the delivery of the requested product to a consumer. Other embodiments include a vending machine that is placed into a retail environment in which software enforces validation of the purchasers' identities, limits the amount of pseudoephedrine for each purchaser within the regulations of local, state and federal agencies.This invention reduces the resources which must be expended in retail locations to comply with regulatory agencies, to implement effective counter measures against illegal purchases of regulated and controlled substances, and to ensure the effective limitation of these substances within reasonable limits required for normal consumption.

The invention relates generally to ephedrine or pseudoephedrine compositions containing biocompatible organoleptic (food flavoring) excipients that would prevent the illicit manufacture of methamphetamine from ephedrine or pseudoephedrine.

A pharmaceutical composition comprising a therapeutically effective amount of a mixture consisting essentially of(i) pseudoephedrine, an individual optical isomer or a pharmaceutically acceptable salt thereof, and(ii) at least one compound selected from 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acid or amide derivatives, an individual optical isomer or a pharmaceutically acceptable salt thereof.

The present invention provides synthetic immunochemical haptens for the generation of antibodies that are designed to recognize the common molecular features of d-methamphetamine-like abused stimulants with insignificant cross-reactivity to endogenous substrates (e.g. dopamine) or over-the-counter medications (e.g. 1-methamphetamine, pseudoephedrine, phenylpropanolamine and ephedrine). These monoclonal antibodies and their antigen binding fragments are useful in treatment plans for recovering addicts, in emergency room settings for rapidly reversing a drug overdose, in protection of fetuses from drug-abusing pregnant mothers or in a psychiatric setting to reduce the exacerbation of psychotic disorders caused by stimulant drugs.

The present invention relates to a compound preparation containing antiviral drug arbidol, which is especially adapted to respiratory tract infection disease caused by virus. During the respiratory tract infection period, the patient has the discomfort symptoms of fever and nose stuff, therefore, the anti influenza compound preparation on the invention also includes one, two or three of the ibuprofen, alcaine pseudoephedrine, and dextromethorphan hydrobromide on the basis of including alcaine arbidol, and is then added with take orally preparation medicinal adjuvant to make take orally solid dosage forms. The medical effect experiment shows that the cooperation of the active components in the compound preparation is well, and the preparation is convenient in used by patient.

A retraction cord for retracting gingival tissue is pre-impregnated with a chemical agent for chemically retracting gingival tissue and / or a hemostatic agent for arresting bleeding. A wetting agent is further applied to the cord to ensure product efficacy and shelf stability. The retracting agent may be an astringent water soluble organic salt such as aluminum potassium sulfate, aluminum sulfate, aluminum chloride, or ferric sulfate-or an inorganic salt of organic vascoconstrictors such as epinephrine, pseudoephedrine, or VISINE. The wetting agent is preferably a non-ionic surface active surfactant such as SILWET L-7607 at a concentration of 0.05% by volume.

The invention discloses a method for simultaneously measuring seven index components in formula granules of Huagai powder for treatment of wind-cold-caused common cold and asthma by using high performance liquid chromatography. The seven index components include ephedrine hydrochloride, pseudoephedrine, amygdalin, glycyrrhizic acid, liquiritin, sanggenon C, and sanggenon D. The method comprises the following steps: step one, preparing a standard solution; step two, preparing a test sample solution; step three, carrying out liquid chromatogram separation; step four, performing a content calculation method. According to the invention, the pretreatment method of sample extraction is simple and the index components can be extracted fully. The method is performed accurately and rapidly with high sensitivity and low cost; and various methodological indexes can satisfy the actual detection demands. Seven measured compounds have high linearity in a standard curve linear range, wherein R2 is larger than 0.9990; the within-day precision relative standard offsets of all components are less than 1.0%; and the day-to-day precision relative standard offsets are less than 3.0%. The recovery ratesof the seven index components are in a range of 90.0% to 110.9%.

The invention relates to a slow release preparation taking acetyl aminophenol, pseudoephedrine or physiologically acceptable slat thereof and dextromethorphan or physiologically acceptable slat thereof as active ingredients. The slow release preparation is characterized in that a releasing system comprises a tablet core and / or pill core capable of enabling a medicament to slowly release and a coating, wherein one part and / or all of the active ingredients exist in the tablet core and / or pill core, and the rest of the active ingredients exist in the coating.

Drug substances comprising a amine containing pharmaceutically active compound, and at least one of an alditol acetal and an aromatic organic acid as an addition salt or an additive.